Sun Pharmaceuticals Industries Ltd 30 January 2025 1820 Put

Sun Pharmaceuticals Industries Ltd 30 January 2025 1820 Put

Q: What is the Sun Pharmaceuticals Industries Ltd 30 January 2025 1820 Put Option?

The Sun Pharmaceuticals Industries Ltd 30 January 2025 1820 Put Option is a financial contract that gives the holder the right, but not the obligation, to sell the Sun Pharmaceuticals Industries Ltd stock at a strike price of 25,200 on 5th September 2024. It is used to hedge against or speculate on a decline in the Sun Pharmaceuticals Industries Ltd stock. Its value depends on the stock's performance relative to the strike price.

Q: What is the significance of the strike price in Sun Pharmaceuticals Industries Ltd 30 January 2025 1820 Put?

The significance of the strike price of 25,200 in the Sun Pharmaceuticals Industries Ltd 30 January 2025 1820 Put Option is the level at which the holder can sell the Sun Pharmaceuticals Industries Ltd stock. It determines the point at which the Option becomes profitable if the stock falls below this value. The significance lies in its impact on the Option's potential value and profitability based on Sun Pharmaceuticals Industries Ltd's movement.

Q: How does the expiry date affect the Sun Pharmaceuticals Industries Ltd 30 January 2025 1820 Put?

The expiry date determines the final opportunity to exercise the Sun Pharmaceuticals Industries Ltd 30 January 2025 1820 Put Option. As the expiry approaches, the time value diminishes, potentially reducing its price. The Option's value is influenced by the Sun Pharmaceuticals Industries Ltd stock's movement relative to the strike price as the expiry date nears.

Q: Can the Sun Pharmaceuticals Industries Ltd 30 January 2025 1820 Put be sold before expiry?

Yes, the Sun Pharmaceuticals Industries Ltd 30 January 2025 1820 Put can be sold before expiry. Selling the Option before expiry allows you to avail any gains or limit losses based on the Option's current market value. The price at which you can sell it depends on market conditions and the Sun Pharmaceuticals Industries Ltd stock's performance.